Dr. Nagourney's Blog

Email-box.png

Informative articles sent right to your inbox. Subscribe to Dr. Nagourney's blog today.

Seventh Time’s the Charm-Unexpected Response in Relapsed Leukemia
By Robert A. Nagourney, MD
For medical oncologists, the choice of chemotherapy drugs is one of statistical probability. For cancer patients, it is a matter of life and death. The problem is that cancer patients are not statistics and each patient responds quite uniquely....
The Avastin Saga Continues
By Robert A. Nagourney, MD
We previously wrote about bevacizumab (Avastin) and its approval for breast cancer. The early clinical trials revealed evidence...
Chronic Lymphocytic Leukemia (CLL) - Model for Functional Profiling
By Robert A. Nagourney, MD
Among the most common forms of leukemia in adults is chronic lymphocytic leukemia CLL.
Revolutionizing Treatment for Hairy Cell Leukemia Patients
By Robert A. Nagourney, MD
Hairy cell leukemia is a rare malignancy characterized by spleen enlargement and progressive anemia and thrombocytopenia (low...

most popular articles

patient story

How We Helped David Hanbidge

"I'll never forget the day when the doctor took my wife and me to a small back office and told us the horrible news…I had the very worst kind of lung cancer..."   Read about how we helped David.